Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 404

1.

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.

Bangalore S, Maron DJ, Fleg JL, O'Brien SM, Herzog CA, Stone GW, Mark DB, Spertus JA, Alexander KP, Sidhu MS, Chertow GM, Boden WE, Hochman JS; ISCHEMIA-CKD Research Group.

Am Heart J. 2018 Aug 1;205:42-52. doi: 10.1016/j.ahj.2018.07.023. [Epub ahead of print]

PMID:
30172098
2.

Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates.

Levy WC, Hellkamp AS, Mark DB, Poole JE, Shadman R, Dardas TF, Anderson J, Johnson G, Fishbein DP, Lee KL, Linker DT, Bardy GH.

JACC Clin Electrophysiol. 2018 Aug;4(8):1089-1102. doi: 10.1016/j.jacep.2018.04.015. Epub 2018 Jun 27.

PMID:
30139491
3.

Palliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL-HF trial.

Mentz RJ, O'Connor CM, Granger BB, Yang H, Patel CB, Steinhauser KE, Fiuzat M, Johnson KS, Anstrom KJ, Dodson GC, Taylor DH Jr, Mark DB, Tulsky JA, Rogers JG.

Am Heart J. 2018 Oct;204:202-204. doi: 10.1016/j.ahj.2018.07.010. Epub 2018 Jul 20. No abstract available.

PMID:
30100051
4.

Long-term outcomes of mitral regurgitation by type and severity.

Samad Z, Shaw LK, Phelan M, Glower DD, Ersboll M, Toptine JH, Alexander JH, Kisslo JA, Wang A, Mark DB, Velazquez EJ.

Am Heart J. 2018 Sep;203:39-48. doi: 10.1016/j.ahj.2018.05.001. Epub 2018 May 18.

PMID:
30015067
5.

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.

ISCHEMIA Trial Research Group, Maron DJ, Hochman JS, O'Brien SM, Reynolds HR, Boden WE, Stone GW, Bangalore S, Spertus JA, Mark DB, Alexander KP, Shaw L, Berger JS, Ferguson TB Jr, Williams DO, Harrington RA, Rosenberg Y.

Am Heart J. 2018 Jul;201:124-135. doi: 10.1016/j.ahj.2018.04.011. Epub 2018 Apr 21.

PMID:
29778671
6.

Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.

Sharma A, Al-Khatib SM, Ezekowitz JA, Cooper LB, Fordyce CB, Michael Felker G, Bardy GH, Poole JE, Thomas Bigger J, Buxton AE, Moss AJ, Friedman DJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Peterson ED, Inoue LYT, Sanders GD.

Eur J Heart Fail. 2018 Jun;20(6):1031-1038. doi: 10.1002/ejhf.1192. Epub 2018 May 15.

PMID:
29761861
7.

Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design.

Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Moretz K, Poole JE, Mascette A, Rosenberg Y, Jeffries N, Al-Khalidi HR, Lee KL; CABANA Investigators.

Am Heart J. 2018 May;199:192-199. doi: 10.1016/j.ahj.2018.02.015. Epub 2018 Mar 7.

8.

Revascularization in stable coronary disease: evidence and uncertainties.

Katritsis DG, Mark DB, Gersh BJ.

Nat Rev Cardiol. 2018 Jul;15(7):408-419. doi: 10.1038/s41569-018-0006-z. Review.

PMID:
29654257
9.

Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy.

Stewart RAH, Szalewska D, Stebbins A, Al-Khalidi HR, Cleland JGH, Rynkiewicz A, Drazner MH, White HD, Mark DB, Roy A, Kosevic D, Rajda M, Jasinski M, Leng CY, Tungsubutra W, Desvigne-Nickens P, Velazquez EJ, Petrie MC.

Open Heart. 2018 Feb 20;5(1):e000752. doi: 10.1136/openhrt-2017-000752. eCollection 2018.

10.

Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial.

Ferencik M, Mayrhofer T, Bittner DO, Emami H, Puchner SB, Lu MT, Meyersohn NM, Ivanov AV, Adami EC, Patel MR, Mark DB, Udelson JE, Lee KL, Douglas PS, Hoffmann U.

JAMA Cardiol. 2018 Feb 1;3(2):144-152. doi: 10.1001/jamacardio.2017.4973.

PMID:
29322167
11.

Effect of high-dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT).

Issa OM, Roberts R, Mark DB, Boineau R, Goertz C, Rosenberg Y, Lewis EF, Guarneri E, Drisko J, Magaziner A, Lee KL, Lamas GA.

Am Heart J. 2018 Jan;195:70-77. doi: 10.1016/j.ahj.2017.09.002. Epub 2017 Sep 8.

12.

Patient-Reported Outcomes in Revascularization Decisions for Left-Main Disease: Sharing the EXCELlence.

Mark DB, Patel MR.

J Am Coll Cardiol. 2017 Dec 26;70(25):3123-3126. doi: 10.1016/j.jacc.2017.10.059. No abstract available.

PMID:
29097295
13.

Impact of Diabetes Mellitus on the Evaluation of Stable Chest Pain Patients: Insights From the PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) Trial.

Sharma A, Sekaran NK, Coles A, Pagidipati NJ, Hoffmann U, Mark DB, Lee KL, Al-Khalidi HR, Lu MT, Pellikka PA, Trong QA, Douglas PS.

J Am Heart Assoc. 2017 Oct 31;6(11). pii: e007019. doi: 10.1161/JAHA.117.007019.

14.

Quality of life in patients with implantable cardioverter-defibrillator: systematic review of randomized controlled trials.

da Silva KR, Costa R, Rodrigues CG, Schasechter A, Nobre MC, Passman R, Mark DB.

Eur J Cardiovasc Nurs. 2018 Mar;17(3):196-206. doi: 10.1177/1474515117739619. Epub 2017 Oct 25.

PMID:
29067836
15.

Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease: a cross-sectional study in North America.

Ladapo JA, Coles A, Dolor RJ, Mark DB, Cooper L, Lee KL, Goldberg J, Shapiro MD, Hoffmann U, Douglas PS.

BMJ Open. 2017 Sep 29;7(9):e016364. doi: 10.1136/bmjopen-2017-016364.

16.

Comparison of Incidence of Left Ventricular Systolic Dysfunction Among Patients With Left Bundle Branch Block Versus Those With Normal QRS Duration.

Sze E, Dunning A, Loring Z, Atwater BD, Chiswell K, Daubert JP, Kisslo JA, Mark DB, Velazquez EJ, Samad Z.

Am J Cardiol. 2017 Dec 1;120(11):1990-1997. doi: 10.1016/j.amjcard.2017.08.003. Epub 2017 Aug 30.

PMID:
28958452
17.

New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials.

Friedman DJ, Al-Khatib SM, Zeitler EP, Han J, Bardy GH, Poole JE, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD.

Am Heart J. 2017 Sep;191:21-29. doi: 10.1016/j.ahj.2017.06.002. Epub 2017 Jun 9. Review.

18.

Safety of coronary CT angiography and functional testing for stable chest pain in the PROMISE trial: A randomized comparison of test complications, incidental findings, and radiation dose.

Lu MT, Douglas PS, Udelson JE, Adami E, Ghoshhajra BB, Picard MH, Roberts R, Lee KL, Einstein AJ, Mark DB, Velazquez EJ, Carter W, Ridner M, Al-Khalidi HR, Hoffmann U.

J Cardiovasc Comput Tomogr. 2017 Sep - Oct;11(5):373-382. doi: 10.1016/j.jcct.2017.08.005. Epub 2017 Aug 15.

19.

The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study.

Hess PL, Al-Khalidi HR, Friedman DJ, Mulder H, Kucharska-Newton A, Rosamond WR, Lopes RD, Gersh BJ, Mark DB, Curtis LH, Post WS, Prineas RJ, Sotoodehnia N, Al-Khatib SM.

J Am Heart Assoc. 2017 Aug 23;6(8). pii: e006103. doi: 10.1161/JAHA.117.006103.

20.

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy-Breakthrough in Low-Density Lipoprotein Cholesterol Lowering, Breakdown in Value.

Mark DB, Richman I, Hlatky MA.

JAMA Cardiol. 2017 Oct 1;2(10):1066-1068. doi: 10.1001/jamacardio.2017.2911. No abstract available.

PMID:
28832860

Supplemental Content

Loading ...
Support Center